Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Assembly Biosciences (ASMB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 708,668
  • Shares Outstanding, K 19,940
  • Annual Sales, $ 0 K
  • Annual Income, $ -44,260 K
  • 36-Month Beta 0.69
  • Price/Sales 124.33
  • Price/Cash Flow N/A
  • Price/Book 12.88

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.00 +31.63%
on 11/02/17
36.90 -3.69%
on 11/17/17
+4.34 (+13.91%)
since 10/17/17
3-Month
24.17 +47.04%
on 08/18/17
36.90 -3.69%
on 11/17/17
+10.96 (+44.59%)
since 08/17/17
52-Week
11.07 +221.05%
on 12/22/16
36.90 -3.69%
on 11/17/17
+22.72 (+177.22%)
since 11/17/16

Most Recent Stories

More News
Assembly Biosciences to Present at the Jefferies London Healthcare Conference

Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics...

ASMB : 35.54 (+1.69%)
Assembly Biosciences Announces Pricing of $60 Million Offering of Common Stock

Assembly Biosciences, Inc. (NASDAQ:ASMB) ("Assembly" or the "Company"), a clinical-stage biotechnology company advancing a new class of oral therapeutic candidates for the treatment of hepatitis B virus...

ASMB : 35.54 (+1.69%)
Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics...

ASMB : 35.54 (+1.69%)
Assembly Biosciences Announces 2017 AASLD Presentations

Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics...

ASMB : 35.54 (+1.69%)
Assembly Biosciences Selects Next-Generation CpAM Candidate for Advancement into Clinical Development

Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics...

ASMB : 35.54 (+1.69%)
New Strong Sell Stocks for September 18th

Here are 4 stocks added to the Zacks Rank #5 (Strong Sell) List today:

AIRG : 9.40 (+2.84%)
ASMB : 35.54 (+1.69%)
APEI : 24.80 (-0.60%)
LNDNY : 18.2600 (+1.44%)
New Strong Sell Stocks for August 31st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

ENDP : 7.54 (+3.29%)
FLO : 19.78 (-1.88%)
CLB : 100.51 (+0.48%)
ASMB : 35.54 (+1.69%)
BKD : 10.42 (+1.07%)
Assembly Biosciences Announces September Conference Participation

Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics...

ASMB : 35.54 (+1.69%)
New Strong Sell Stocks for August 16th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

BECN : 55.63 (+0.83%)
AEGN : 26.74 (+0.07%)
ASMB : 35.54 (+1.69%)
XRAY : 67.55 (+0.55%)
JACK : 105.03 (+0.56%)
Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics...

ASMB : 35.54 (+1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for...

See More

Key Turning Points

2nd Resistance Point 37.88
1st Resistance Point 36.71
Last Price 35.54
1st Support Level 34.56
2nd Support Level 33.58

See More

52-Week High 36.90
Last Price 35.54
Fibonacci 61.8% 27.03
Fibonacci 50% 23.99
Fibonacci 38.2% 20.94
52-Week Low 11.07

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart